Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 847-971-4 | CAS number: 2363126-59-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30 March 2020 - 08 July 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Version / remarks:
- 17 December 2001
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Version / remarks:
- December 2002
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Agriculture, Forestry and Fisheries, Test Data for Registration of Agricultural Chemicals, Acute oral toxicity (2-1-1), 12 Nousan No 8147,
- Version / remarks:
- November 24, 2000.
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- no
Test material
- Reference substance name:
- Manganese-(II)-hexacyanomanganate (II) sodium salts
- EC Number:
- 847-971-4
- Cas Number:
- 2363126-59-2
- Molecular formula:
- NaxMny[Mn(CN)6]z X = 1.2-1.4; Y = 1.0; Z = 0.8-0.85
- IUPAC Name:
- Manganese-(II)-hexacyanomanganate (II) sodium salts
- Reference substance name:
- Water
- EC Number:
- 231-791-2
- EC Name:
- Water
- Cas Number:
- 7732-18-5
- Molecular formula:
- H2O
- IUPAC Name:
- Oxidane
- Test material form:
- solid: particulate/powder
Constituent 1
impurity 1
- Specific details on test material used for the study:
- See description in the test substance section
Test animals
- Species:
- rat
- Strain:
- other: RccHan™:WIST albino
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Rationale for alternative/additional species to rat (if applicable): not applicable
- Source: Envigo RMS (UK) Ltd
- Females (if applicable) nulliparous and non-pregnant: [yes]
- Rationale for use of males (if applicable): not applicable
- Age at study initiation: eight to twelve weeks of age
- Weight at study initiation: 154 to 181 g
- Fasting period before study: overnight prior to dosing
- Housing: solid bottomed polycarbonate cages with a stainless steel mesh lid. Each cage contained a quantity of autoclaved softwood bark-free fiber bedding. Cages, food hoppers, water bottles and bedding were changed at appropriate intervals.
- Diet (e.g. ad libitum): ad libitum, Teklad 2014C Diet
- Water (e.g. ad libitum): ad libitum, Potable water taken from the public supply
- Acclimation period: not specified
- Microbiological status when known: not specified
- Method of randomisation in assigning animals to test and control groups: not specified
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 24°C
- Humidity (%): 40 to 70%
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: Sighting study: 300 - 50 - 5 mg/kg anhydrous test substance in Corn Oil; Main study: 5 mg/kg anhydrous test substance in Corn Oil
- Amount of vehicle (if gavage): 10 mL/kg
- Justification for choice of vehicle:
- Lot/batch no. (if required):
- Purity:
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg
DOSAGE PREPARATION (if unusual):not applicable - Doses:
- Range finder: 300 - 50 - 5 mg/kg
Main study: 5 mg/kg - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days (or other?)
14 d
- Frequency of observations and weighing: d 0, 1, 8 and 15
- Necropsy of survivors performed: yes : Subcutaneous tissue, Brain, Heart, Lungs and bronchi, Liver, Spleen, Kidneys, Stomach, Duodenum, Small Intestines, Large Intestines, Cecum, Urinary Bladder
- Clinical signs including body weight: Unsteady gait, Decreased activity, Irregular breathing, Convulsion, Flattened posture, Rapid breathing, Shallow breathing, Prostrate posture, Unresponsive behavior
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: yes
Results and discussion
- Preliminary study:
- The female (number 61) dosed at 347 mg/kg in the sighting study died approximately nine minutes after dosing and the females (animal number 62) dosed at 57.8 mg/kg was killed approximately 50 minutes after dosing.
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 5 mg/kg bw
- Based on:
- test mat.
- Remarks:
- (anhydrous content)
- Mortality:
- The female (number 61) dosed at 347 mg/kg in the sighting study died approximately nine minutes after dosing and the females (animal number 62) dosed at 57.8 mg/kg was killed approximately 50 minutes after dosing.
Clinical signs prior to death for female 61 (dosed at 347 mg/kg) comprised unsteady gait, decreased activity, irregular breathing, convulsion and flattened posture. These signs were seen from approximately five minutes after dosing. Macroscopic examination of this animal revealed a congestion (darkened tissue/organ) of the liver, blue fluid with blue flecks in the stomach, small and large intestines, and in the cecum. Also, a fluid with blue flecks was observed in the duodenum.
Clinical signs prior to death for female 62 (dosed at 57.8 mg/kg) comprised rapid breathing, decreased activity, shallow breathing, prostrate posture and unresponsive behavior. These signs were seen from approximately 30 minutes after dosing. Macroscopic examination of this animal revealed congestion (darkened tissue/organ) of the liver and lungs and bronchi. In addition, a fluid with blue flecks was observed in the stomach. - Clinical signs:
- other: No clinical signs were observed in any animal dosed at 5.78 mg/kg in the sighting study or main study.
- Gross pathology:
- No abnormalities were noted in any animal dosed at 5.78 mg/kg at the macroscopic examination at study termination on Day 15.
- Other findings:
- not reported
Any other information on results incl. tables
Dose (mg/kg) |
No. of deaths |
Day@ |
|
|||
1 |
2 to 15 |
|
||||
<9m |
<50 |
a |
b |
|
||
Sighting study |
||||||
347* |
1/1F |
1 |
- |
- |
- |
|
57.8** |
1/1F |
0 |
1 |
- |
- |
|
5.78*** |
0/1F |
0 |
0 |
0 |
0 |
|
Main study |
||||||
5.78*** |
0/4F |
0 |
0 |
0 |
0 |
|
* 347 mg/kg was the test item as supplied which was equivalent to 300 mg/kg of the anhydrous test item. ** 57.8 mg/kg was the test item as supplied which was equivalent to 50 mg/kg of the anhydrous test item. *** 5.78 mg/kg was the test item as supplied which was equivalent to 5 mg/kg of the anhydrous test item.
@ The day/time indicated is the time that the animal was found dead/killed for humane reasons F Female m Minutes a First observation b Second observation - Not applicable |
Applicant's summary and conclusion
- Interpretation of results:
- Category 2 based on GHS criteria
- Conclusions:
- The acute median lethal oral dose (LD50) to rats of the test item was demonstrated to be between 5.78 and 57.8 mg/kg body weight (equivalent to 5 and 50 mg/kg anhydrous test item).
Accordingly the test item is included in Category 2, according to the Globally Harmonised System (GHS). - Executive summary:
The study was performed to assess the acute oral toxicity of the test item, an industrial chemical, to the rat.
Fasted female rats received a single oral gavage dose of the test item, formulated in dried corn oil, at the following dose levels:
- Sighting investigations: 347*, 57.8** and 5.78*** mg/kg body weight
- Main study: Based on the results of the sighting investigations a further four fasted females were similarly dosed at 5.78*** mg/kg body weight.
* 347 mg/kg was the test item as supplied which was equivalent to 300 mg/kg of the anhydrous test item.
** 57.8 mg/kg was the test item as supplied which was equivalent to 50 mg/kg of the anhydrous test item.
*** 5.78 mg/kg was the test item as supplied which was equivalent to 5 mg/kg of the anhydrous test item.
During the study, clinical condition, body weight and macropathology investigations were undertaken.
Results
The female (number 61) dosed at 347 mg/kg in the sighting study died approximately nine minutes after dosing and the females (animal number 62) dosed at 57.8 mg/kg was killed approximately 50 minutes after dosing.
Clinical signs prior to death for female 61 (dosed at 347 mg/kg) comprised unsteady gait, decreased activity, irregular breathing, convulsion and flattened posture. These signs were seen from approximately five minutes after dosing. Macroscopic examination of this animal revealed a congestion (darkened tissue/organ) of the liver, blue fluid with blue flecks in the stomach, small and large intestines, and in the cecum. Also, a fluid with blue flecks was observed in the duodenum.
Clinical signs prior to death for female 62 (dosed at 57.8 mg/kg) comprised rapid breathing, decreased activity, shallow breathing, prostrate posture and unresponsive behavior. These signs were seen from approximately 30 minutes after dosing. Macroscopic examination of this animal revealed congestion (darkened tissue/organ) of the liver and lungs and bronchi. In addition, a fluid with blue flecks was observed in the stomach.
No clinical signs were observed in any animal dosed at 5.78 mg/kg in the sighting study or main study.
All surviving animals were considered to have achieved satisfactory body weight gains throughout the study.
No abnormalities were noted in any animal dosed at 5.78 mg/kg at the macroscopic examination at study termination on Day 15.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.